[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  @drsprs Dr. S Dr. S posts on X about $cere, $krtx, $etnb, discount the most. They currently have XXXXX followers and XX posts still getting attention that total XXX engagements in the last XX hours. ### Engagements: XXX [#](/creator/twitter::182541217/interactions)  - X Week XXX -XX% - X Month XXXXXX +440% - X Months XXXXXX -XX% - X Year XXXXXXX +202% ### Mentions: X [#](/creator/twitter::182541217/posts_active)  - X Week XX no change - X Month XX +90% - X Months XX -XX% - X Year XXX +22% ### Followers: XXXXX [#](/creator/twitter::182541217/followers)  - X Week XXXXX +1.20% - X Month XXXXX +5.70% - X Months XXXXX +20% - X Year XXXXX +53% ### CreatorRank: XXXXXXXXX [#](/creator/twitter::182541217/influencer_rank)  ### Social Influence [#](/creator/twitter::182541217/influence) --- **Social category influence** [cryptocurrencies](/list/cryptocurrencies) XXXX% [social networks](/list/social-networks) XXXX% [technology brands](/list/technology-brands) XXXX% [stocks](/list/stocks) XXXX% [finance](/list/finance) XXXX% **Social topic influence** [$cere](/topic/$cere) #2, [$krtx](/topic/$krtx) #2, [$etnb](/topic/$etnb) #3, [discount](/topic/discount) #2233, [$gral](/topic/$gral) 1.79%, [imo](/topic/imo) 1.79%, [$tdoc](/topic/$tdoc) 1.79%, [$dkng](/topic/$dkng) 1.79%, [twitter](/topic/twitter) 1.79%, [contra](/topic/contra) XXXX% **Top accounts mentioned or mentioned by** [@notjanetyellen7](/creator/undefined) [@valuedig](/creator/undefined) [@bronxb_13](/creator/undefined) [@knightcharo](/creator/undefined) [@bronxb13](/creator/undefined) [@msollender](/creator/undefined) [@goderguy](/creator/undefined) [@aaronrosenblum5](/creator/undefined) [@west0_cap](/creator/undefined) [@dancingtapas](/creator/undefined) [@markland55](/creator/undefined) [@avidresearch](/creator/undefined) [@askbio](/creator/undefined) [@monacobiotech](/creator/undefined) [@wexcapital](/creator/undefined) [@andersresearch](/creator/undefined) [@susanbenali](/creator/undefined) [@miamkitty](/creator/undefined) [@jlvle](/creator/undefined) [@michellefdavis](/creator/undefined) **Top assets mentioned** [Cere Network (CERE)](/topic/$cere) [Karuna Therapeutics, Inc. Common Stock (KRTX)](/topic/$krtx) [GRAIL, Inc. Common Stock (GRAL)](/topic/$gral) [Teladoc Health, Inc. (TDOC)](/topic/$tdoc) [DraftKings Inc. Class A Common Stock (DKNG)](/topic/$dkng) [Sea Limited (SE)](/topic/$se) [Snap, Inc. (SNAP)](/topic/$snap) [Merus N.V. Common Shares (MRUS)](/topic/$mrus) [Club Atletico Independiente Fan Token (CAI)](/topic/$cai) ### Top Social Posts [#](/creator/twitter::182541217/posts) --- Top posts by engagements in the last XX hours "Some cash burning shitcos should raise capital if possible with this trash rally. Example $GRAL why did it 3X from April. Any other come to mind" [X Link](https://x.com/drsprs/status/1974156399178657928) [@drsprs](/creator/x/drsprs) 2025-10-03T16:55Z 2182 followers, 3936 engagements "This is an identical situation to $CERE v. $KRTX a few years back. This is essentially a time arbitrage with binary risk. $ETNB drug "probably" works like XX% chance imo but you have to wait for the readout. So the stock price currently reflects that discount. If a pharma wants to take a chance and get a discount they probably could buy them out for $XX a share I bet BOD would take it. However there is a real binary risk for a pharma later on it didn't work out well for Cerevel and Abbvie so far" [X Link](https://x.com/drsprs/status/1884705797739078080) [@drsprs](/creator/x/drsprs) 2025-01-29T20:50Z 2184 followers, 6502 engagements "Wow I was close thought $XX buy out. $XXXXX + $X CVR = $XXXXX total potentially. #biosquidgames pick $ETNB" [X Link](https://x.com/drsprs/status/1968552276932304958) [@drsprs](/creator/x/drsprs) 2025-09-18T05:46Z 2182 followers, 4917 engagements "Are you having trouble sorting out the markets Here are X great contras on Twitter. Back tested and extremely reverse accurate. 👇 Not trying to be mean just truthful my wife is my best trading contra she just doesn't know it. 😂 $TDOC $SE $SNAP $DKNG" [X Link](https://x.com/drsprs/status/1618839776408510469) [@drsprs](/creator/x/drsprs) 2023-01-27T05:14Z 2184 followers, 1497 engagements "@JlVlE @NotJanetYellen7 RGEN DHR DIM" [X Link](https://x.com/drsprs/status/1974296918164693407) [@drsprs](/creator/x/drsprs) 2025-10-04T02:14Z 2176 followers, XXX engagements "$MXCT $CLPT are "toll collectors." At first glance they are attractive since they avoid direct program risk but overall they extract a very small portion of the overall revenue per pt. So they need to have multiple killer apps (commercial) to be scalable + profitable long term. Casgevy is not it. It's clearly not so far. But Maxcyte does have tons of clinical progs in the works do any look like commercial blockbusters $CLPT looks they have X potentially in AMT-130 by $QURE. But look at the financials base case 1000 pts/yr. Uniqure gets 2Mx1000=2B. Clearpoint gets 20Kx1000=20M. Underwhelming." [X Link](https://x.com/drsprs/status/1974531283817767270) [@drsprs](/creator/x/drsprs) 2025-10-04T17:45Z 2184 followers, 3128 engagements "For all the chatter that Europe is an aging relic with no innovation European biotechs the past X years have made huge impacts on standard of care in medicine. Argenx $ARGX ➡ any IVIG indication Ascendis $ASND ➡ hypoparathyroidism Abivax $ABVX ➡ effective oral option for UC Adaptimmune $ADAP ➡ synovial sarcoma Immunocore $IMCR ➡ uveal melanoma Merus $MRUS ➡ head and neck cancer and possibly colorectal cancer Uniqure $QURE ➡ Huntington's disease Practice changing medications probably people need to rethink their opinion on European biotech" [X Link](https://x.com/drsprs/status/1970878114600501441) [@drsprs](/creator/x/drsprs) 2025-09-24T15:48Z 2184 followers, 10.5K engagements "$CAI first Q as public co looks totally different from their private years. Gross margin went from 30s to 60s ASP up 50+% and test volume up XX% (vol is believable). Is this real and/or sustainable Any opinions" [X Link](https://x.com/drsprs/status/1955683249352741009) [@drsprs](/creator/x/drsprs) 2025-08-13T17:29Z 2160 followers, 2421 engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Dr. S posts on X about $cere, $krtx, $etnb, discount the most. They currently have XXXXX followers and XX posts still getting attention that total XXX engagements in the last XX hours.
Social category influence cryptocurrencies XXXX% social networks XXXX% technology brands XXXX% stocks XXXX% finance XXXX%
Social topic influence $cere #2, $krtx #2, $etnb #3, discount #2233, $gral 1.79%, imo 1.79%, $tdoc 1.79%, $dkng 1.79%, twitter 1.79%, contra XXXX%
Top accounts mentioned or mentioned by @notjanetyellen7 @valuedig @bronxb_13 @knightcharo @bronxb13 @msollender @goderguy @aaronrosenblum5 @west0_cap @dancingtapas @markland55 @avidresearch @askbio @monacobiotech @wexcapital @andersresearch @susanbenali @miamkitty @jlvle @michellefdavis
Top assets mentioned Cere Network (CERE) Karuna Therapeutics, Inc. Common Stock (KRTX) GRAIL, Inc. Common Stock (GRAL) Teladoc Health, Inc. (TDOC) DraftKings Inc. Class A Common Stock (DKNG) Sea Limited (SE) Snap, Inc. (SNAP) Merus N.V. Common Shares (MRUS) Club Atletico Independiente Fan Token (CAI)
Top posts by engagements in the last XX hours
"Some cash burning shitcos should raise capital if possible with this trash rally. Example $GRAL why did it 3X from April. Any other come to mind"
X Link @drsprs 2025-10-03T16:55Z 2182 followers, 3936 engagements
"This is an identical situation to $CERE v. $KRTX a few years back. This is essentially a time arbitrage with binary risk. $ETNB drug "probably" works like XX% chance imo but you have to wait for the readout. So the stock price currently reflects that discount. If a pharma wants to take a chance and get a discount they probably could buy them out for $XX a share I bet BOD would take it. However there is a real binary risk for a pharma later on it didn't work out well for Cerevel and Abbvie so far"
X Link @drsprs 2025-01-29T20:50Z 2184 followers, 6502 engagements
"Wow I was close thought $XX buy out. $XXXXX + $X CVR = $XXXXX total potentially. #biosquidgames pick $ETNB"
X Link @drsprs 2025-09-18T05:46Z 2182 followers, 4917 engagements
"Are you having trouble sorting out the markets Here are X great contras on Twitter. Back tested and extremely reverse accurate. 👇 Not trying to be mean just truthful my wife is my best trading contra she just doesn't know it. 😂 $TDOC $SE $SNAP $DKNG"
X Link @drsprs 2023-01-27T05:14Z 2184 followers, 1497 engagements
"@JlVlE @NotJanetYellen7 RGEN DHR DIM"
X Link @drsprs 2025-10-04T02:14Z 2176 followers, XXX engagements
"$MXCT $CLPT are "toll collectors." At first glance they are attractive since they avoid direct program risk but overall they extract a very small portion of the overall revenue per pt. So they need to have multiple killer apps (commercial) to be scalable + profitable long term. Casgevy is not it. It's clearly not so far. But Maxcyte does have tons of clinical progs in the works do any look like commercial blockbusters $CLPT looks they have X potentially in AMT-130 by $QURE. But look at the financials base case 1000 pts/yr. Uniqure gets 2Mx1000=2B. Clearpoint gets 20Kx1000=20M. Underwhelming."
X Link @drsprs 2025-10-04T17:45Z 2184 followers, 3128 engagements
"For all the chatter that Europe is an aging relic with no innovation European biotechs the past X years have made huge impacts on standard of care in medicine. Argenx $ARGX âž¡ any IVIG indication Ascendis $ASND âž¡ hypoparathyroidism Abivax $ABVX âž¡ effective oral option for UC Adaptimmune $ADAP âž¡ synovial sarcoma Immunocore $IMCR âž¡ uveal melanoma Merus $MRUS âž¡ head and neck cancer and possibly colorectal cancer Uniqure $QURE âž¡ Huntington's disease Practice changing medications probably people need to rethink their opinion on European biotech"
X Link @drsprs 2025-09-24T15:48Z 2184 followers, 10.5K engagements
"$CAI first Q as public co looks totally different from their private years. Gross margin went from 30s to 60s ASP up 50+% and test volume up XX% (vol is believable). Is this real and/or sustainable Any opinions"
X Link @drsprs 2025-08-13T17:29Z 2160 followers, 2421 engagements
/creator/twitter::drsprs